Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
3.300
-0.233 (-6.59%)
At close: Apr 17, 2025, 4:00 PM
3.224
-0.076 (-2.31%)
Pre-market: Apr 21, 2025, 4:26 AM EDT
Kazia Therapeutics Stock Forecast
KZIA's stock price has decreased by -77.32% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Kazia Therapeutics stock have an average target of 57.5, with a low estimate of 15 and a high estimate of 100. The average target predicts an increase of 1,642.42% from the current stock price of 3.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 6, 2025.
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +354.55% | Feb 6, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +2,930.30% | Jul 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $100 | Hold → Strong Buy | Upgrades | $100 | +2,930.30% | Apr 11, 2023 |
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 2, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 2, 2022 |
Financial Forecast
Revenue This Year
n/a
from 2.48M
Revenue Next Year
n/a
EPS This Year
-5.30
from -10.16
EPS Next Year
-2.59
from -5.30
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -5.46 | -2.67 | -2.07 | ||
Avg | -5.30 | -2.59 | -2.01 | ||
Low | -5.10 | -2.49 | -1.93 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.